Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
07/03/2025 13:36
March 7 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O: VIRPAX LOOKING TO USE MET TO DEVELOP INTRANASAL COVID VACCINE VIRPAX PHARMACEUTICALS INC - TO EXPLORE INTRANASAL VACCINE DELIVERY Source text: ID:nBw1Hsnhra Further company coverage: VRPX.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study